Literature DB >> 19924532

Altered regulation of CD200 receptor in monocyte-derived macrophages from individuals with Parkinson's disease.

Xiao-Guang Luo1, Ji-Juan Zhang, Chao-Dong Zhang, Rong Liu, Lan Zheng, Xi-Jin Wang, Sheng-Di Chen, Jian-Qing Ding.   

Abstract

Microglia are the representative myeloid cells in the brain, and their over-activation plays an important role in the pathogenesis of Parkinson's disease (PD). Microglia activation is believed to be regulated by the CD200-CD200R signaling. As the peripheral counterpart of microglia, monocyte-derived macrophages (MDMs) share the same progenitor and antigen markers, and they have similar biological behaviors and mirror microglial function in the brain. Here, we studied CD200R expression and its regulation in MDMs from 32 PD cases, 27 age-matched old controls, and 28 young controls. We found that the basal CD200R expression is similar in MDMs from young control, old control and PD patients. However, the induction of CD200R expression in MDMs under various conditions is impaired in the old groups, especially in PD patients. There was a selective decrease in CD200R expression induced by co-culture with dying PC12 cells in MDMs from PD cases, as compared with MDMs from the age-matched controls. We also found that the inducible CD200R expression correlated inversely with the onset age of PD and to tumor necrosis factor-alpha (TNF-alpha) released from MDMs. These results suggest an intrinsic abnormality in the CD200-CD200R signaling in MDMs during aging and, especially, in PD. We speculate that in the PD brain,microglia might undergo abnormalities similar to MDMs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19924532     DOI: 10.1007/s11064-009-0094-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Down-regulation of the macrophage lineage through interaction with OX2 (CD200).

Authors:  R M Hoek; S R Ruuls; C A Murphy; G J Wright; R Goddard; S M Zurawski; B Blom; M E Homola; W J Streit; M H Brown; A N Barclay; J D Sedgwick
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

Review 3.  Neuronal 'On' and 'Off' signals control microglia.

Authors:  Knut Biber; Harald Neumann; Kazuhide Inoue; Hendrikus W G M Boddeke
Journal:  Trends Neurosci       Date:  2007-10-24       Impact factor: 13.837

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 5.  Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease.

Authors:  Yoon Seong Kim; Tong H Joh
Journal:  Exp Mol Med       Date:  2006-08-31       Impact factor: 8.718

6.  Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance?

Authors:  Michael D Rosenblum; Edit B Olasz; Kim B Yancey; Jeffrey E Woodliff; Zelmira Lazarova; Kimberly A Gerber; Robert L Truitt
Journal:  J Invest Dermatol       Date:  2004-11       Impact factor: 8.551

7.  Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.

Authors:  Nathalie Koning; Lars Bö; Robert M Hoek; Inge Huitinga
Journal:  Ann Neurol       Date:  2007-11       Impact factor: 10.422

8.  Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

Authors:  Gavin J Wright; Holly Cherwinski; Mildred Foster-Cuevas; Gary Brooke; Michael J Puklavec; Mike Bigler; Yaoli Song; Maria Jenmalm; Dan Gorman; Terri McClanahan; Man-Ru Liu; Marion H Brown; Jonathon D Sedgwick; Joseph H Phillips; A Neil Barclay
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

Review 9.  Parkinson's disease and inflammatory changes.

Authors:  Carlos Barcia; Andrés Fernández Barreiro; Máximo Poza; María-Trinidad Herrero
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 10.  Genetic factors involved in the pathogenesis of Parkinson's disease.

Authors:  Frank J S Lee; Fang Liu
Journal:  Brain Res Rev       Date:  2008-02-11
View more
  13 in total

Review 1.  The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease.

Authors:  Marina A Lynch
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

2.  Peripheral Blood Monocyte Tolerance Alleviates Intraperitoneal Lipopolysaccharides-Induced Neuroinflammation in Rats Via Upregulating the CD200R Expression.

Authors:  Liping Xia; Xin Xie; Yang Liu; Xiaoguang Luo
Journal:  Neurochem Res       Date:  2017-06-29       Impact factor: 3.996

Review 3.  Immune system responses in Parkinson's disease: Early and dynamic.

Authors:  Malú G Tansey; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

4.  Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand.

Authors:  Merav Cohen; Hila Ben-Yehuda; Ziv Porat; Catarina Raposo; Siamon Gordon; Michal Schwartz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

5.  Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.

Authors:  Douglas G Walker; Lih-Fen Lue; Tiffany M Tang; Charles H Adler; John N Caviness; Marwan N Sabbagh; Geidy E Serrano; Lucia I Sue; Thomas G Beach
Journal:  Neurobiol Aging       Date:  2017-03-16       Impact factor: 4.673

6.  The rhesus rhadinovirus CD200 homologue affects immune responses and viral loads during in vivo infection.

Authors:  Ryan D Estep; Stephanie D Rawlings; Helen Li; Minsha Manoharan; Elizabeth T Blaine; Megan A O'Connor; Ilhem Messaoudi; Michael K Axthelm; Scott W Wong
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

7.  Understanding the neurobiology of CD200 and the CD200 receptor: a therapeutic target for controlling inflammation in human brains?

Authors:  Douglas G Walker; Lih-Fen Lue
Journal:  Future Neurol       Date:  2013-05

8.  Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.

Authors:  Russell L Blaylock; Joseph Maroon
Journal:  Surg Neurol Int       Date:  2011-07-30

9.  CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease.

Authors:  Shi Zhang; Xi-Jin Wang; Li-Peng Tian; Jing Pan; Guo-Qiang Lu; Ying-Jie Zhang; Jian-Qing Ding; Sheng-Di Chen
Journal:  J Neuroinflammation       Date:  2011-11-06       Impact factor: 8.322

10.  Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival.

Authors:  Aaron Prodeus; Marzena Cydzik; Aws Abdul-Wahid; Eric Huang; Ismat Khatri; Reginald Gorczynski; Jean Gariépy
Journal:  Mol Ther Nucleic Acids       Date:  2014-08-26       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.